Journal of Clinical Medicine,
Год журнала:
2023,
Номер
12(14), С. 4714 - 4714
Опубликована: Июль 16, 2023
Aging
and
chronic
heart
failure
(CHF)
are
responsible
for
the
temporal
inhomogeneity
of
electrocardiogram
(ECG)
repolarization
phase.
Recently,
some
short
period
repolarization-dispersion
parameters
have
been
proposed
as
markers
acute
decompensation
mortality
risk
in
CHF
patients.
Some
important
differences
between
sexes
known,
but
their
impact
on
ECG
remains
unstudied.
The
aim
this
study
was
to
evaluate
possible
men
women
telemonitoring
5
min
recordings
were
collected
assess
mean
standard
deviation
(SD)
following
variables:
QT
end
(QTe),
peak
(QTp),
T
(Te)
215
decompensated
(age
range:
from
49
103
years).
Thirty-day
high
levels
NT-pro
BNP
(<75
percentile)
considered
CHF.
A
total
34
patients
(16%)
died
during
30-day
follow-up,
without
sexes.
Women
showed
a
more
preserved
ejection
fraction
higher
LDL
cholesterol
levels.
Among
female
patients,
implantable
cardioverter
devices,
statins,
antiplatelet
agents
less
used.
Data
Te
increased
values
among
deceased
compared
survival,
TeSD
shown
be
most
reliable
marker
reacutization
both
could
factor
worsening
complications
male
different
cut
offs
should
taken
into
account.
(ClinicalTrials.gov
number,
NCT04127162.).
Circulation Heart Failure,
Год журнала:
2024,
Номер
17(5)
Опубликована: Май 1, 2024
Heart
failure
(HF)
is
associated
with
poor
outcomes
in
people
chronic
kidney
disease,
yet
it
unknown
whether
differ
by
HF
subtype.
This
study
aimed
to
examine
associations
of
incident
preserved
ejection
fraction
(HFpEF)
versus
reduced
(HFrEF)
progression
end-stage
disease
(ESKD)
and
mortality.
Journal of Clinical Medicine,
Год журнала:
2024,
Номер
13(5), С. 1375 - 1375
Опубликована: Фев. 28, 2024
Heart
failure
with
preserved
ejection
fraction
(HFpEF)
is
characterized
by
a
notable
heterogeneity
in
both
phenotypic
and
pathophysiological
features,
growing
incidence
due
to
the
increase
median
age
comorbidities
such
as
obesity,
arterial
hypertension,
cardiometabolic
disease.
In
recent
decades,
development
of
new
pharmacological
non-pharmacological
options
has
significantly
impacted
outcomes,
improving
clinical
status
reducing
mortality.
Moreover,
more
personalized
accurate
therapeutic
management
been
demonstrated
enhance
quality
life,
diminish
hospitalizations,
improve
overall
survival.
Therefore,
assessing
peculiarities
patients
HFpEF
crucial
order
obtain
better
understanding
this
disorder.
Importantly,
have
shown
influence
symptoms
prognosis,
and,
consequently,
they
should
be
carefully
addressed.
sense,
it
mandatory
join
forces
multidisciplinary
team
achieve
high-quality
care.
However,
remains
largely
under-recognized
under-treated
practice,
diagnostic
these
challenging.
The
aim
paper
articulate
pragmatic
approach
for
focusing
on
etiology,
diagnosis,
treatment
HFpEF.
Journal of Inflammation Research,
Год журнала:
2024,
Номер
Volume 17, С. 3003 - 3012
Опубликована: Май 1, 2024
The
aim
of
this
study
was
to
explore
the
relationship
between
inflammatory
cytokines
and
risk
heart
failure
(HF)
readmission
in
patients
with
preserved
ejection
fraction
(HFpEF).
